Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Status:
Recruiting
Trial end date:
2024-10-10
Target enrollment:
Participant gender:
Summary
The trial is open to all patients with a diagnosis of acute promyelocytic leukemia (APL) who
are PCR-positive for the PML-RARĪ± transcript and less than 18 years of age.
Phase:
Phase 2
Details
Lead Sponsor:
Associazione Italiana Ematologia Oncologia Pediatrica